BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 17662783)

  • 1. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor.
    Juthier F; Vincentelli A; Gaudric J; Corseaux D; Fouquet O; Calet C; Le Tourneau T; Soenen V; Zawadzki C; Fabre O; Susen S; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):843-52. PubMed ID: 16580443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
    Leyh R; Wilhelmi M; Haverich A; Mertsching H
    Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
    Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
    Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding?
    Dohmen PM; da Costa F; Yoshi S; Lopes SV; da Souza FP; Vilani R; Wouk AF; da Costa M; Konertz W
    J Heart Valve Dis; 2006 Nov; 15(6):823-9. PubMed ID: 17152791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
    Hilbert SL; Yanagida R; Souza J; Wolfinbarger L; Jones AL; Krueger P; Stearns G; Bert A; Hopkins RA
    J Heart Valve Dis; 2004 Sep; 13(5):831-40. PubMed ID: 15473487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
    Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells.
    Zhao Y; Zhang S; Zhou J; Wang J; Zhen M; Liu Y; Chen J; Qi Z
    Biomaterials; 2010 Jan; 31(2):296-307. PubMed ID: 19819544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of tissue-engineered homograft bioprosthetic heart valves in vitro.
    Bin F; Yinglong L; Nin X; Kai F; Laifeng S; Xiaodong Z
    ASAIO J; 2006; 52(3):303-9. PubMed ID: 16760720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study.
    Hong H; Dong N; Shi J; Chen S; Guo C; Hu P; Qi H
    Artif Organs; 2009 Jul; 33(7):554-8. PubMed ID: 19566733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
    Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
    Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tissue engineered heart valve implanted in a juvenile sheep model.
    Dohmen PM; Ozaki S; Nitsch R; Yperman J; Flameng W; Konertz W
    Med Sci Monit; 2003 Apr; 9(4):BR97-BR104. PubMed ID: 12709659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-derived, tissue-engineered pulmonary artery augmentation patches in vivo.
    Mettler BA; Sales VL; Stucken CL; Anttila V; Mendelson K; Bischoff J; Mayer JE
    Ann Thorac Surg; 2008 Jul; 86(1):132-40; discussion 140-1. PubMed ID: 18573411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model.
    Baraki H; Tudorache I; Braun M; Höffler K; Görler A; Lichtenberg A; Bara C; Calistru A; Brandes G; Hewicker-Trautwein M; Hilfiker A; Haverich A; Cebotari S
    Biomaterials; 2009 Oct; 30(31):6240-6. PubMed ID: 19703713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.